| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Windtree Therapeutics Inc /de/ (WINT) has 0 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. WINT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2018 | Lee's Pharmaceutical Holdings Ltd | 10% Owner | Buy | 541,667 | $4.80 | $2,600,001.60 | +23.4% | |
| Oct 28, 2016 | Fraser Craig | President And CEO | Buy | 7,500 | $2.05 | $15,381.00 | New | |
| Jul 22, 2015 | Cooper John G | President &CEO | Buy | 41,667 | $0.00 | - | +184.0% | |
| Jul 22, 2015 | Templeton Mary B Esq | SVP, Gen Counsel &Corp Sec | Buy | 16,667 | $0.00 | - | +166.7% | |
| Jul 22, 2015 | Tattory John A | SVP &Chief Financial Officer | Buy | 8,333 | $0.00 | - | +125.0% | |
| Jul 22, 2015 | Simonson Steven | SVP, Chief Development Officer | Buy | 16,667 | $0.00 | - | +83,335% | |
| Jul 22, 2015 | Leone John R | Director | Buy | 50,000 | $0.00 | - | +166.9% |